How have ART treatment programmes changed the patterns of excess mortality in people living with HIV? Estimates from four countries in East and Southern Africa

Global Health Action

Volumn 7, Issue SUPP.1, 2014, Pages

  Slaymaker, Emma ^a   Todd, Jim ^a,b   Marston, Milly ^a   Calvert, Clara ^a   Michael, Denna ^b   Nakiyingi Miiro, Jessica ^c   Crampin, Amelia ^a,d   Lutalo, Tom ^c   Herbst, Kobus ^e   Zaba, Basia ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^c UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^d KARONGA PREVENTION STUDY   (Malawi)

^e UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

ALPHA network; Antiretroviral therapy; HIV; Mortality; Sub Saharan Africa

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ADULT; AGE; ALPHA NETWORK; ANTIRETROVIRAL THERAPY; ARTICLE; FEMALE; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MALAWI; MALE; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; SEX; SOUTH AFRICA; SUB-SAHARAN AFRICA; TANZANIA; UGANDA; YOUNG ADULT;

ALPHA NETWORK; ANTIRETROVIRAL THERAPY; HIV; MORTALITY; SUB-SAHARAN AFRICA;

ADOLESCENT; ADULT; AGE FACTORS; ANTI-HIV AGENTS; FEMALE; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALAWI; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PROPORTIONAL HAZARDS MODELS; SEX; SOUTH AFRICA; TANZANIA; UGANDA; YOUNG ADULT;

EID: 84904396581     PISSN: None     EISSN: 16549880     Source Type: Journal    
DOI: 10.3402/gha.v7.22789     Document Type: Article

References (32)

1. Todd J, Balira R, Grosskurth H, Mayaud P, Mosha F, ka-Gina G, et al. HIV-associated adult mortality in a rural Tanzanian population. AIDS 1997; 11: 801-7.
2. Nunn AJ, Mulder DW, Kamali A, Ruberantwari A, Kengeya- Kayondo JF, Whitworth J. Mortality associated with HIV-1 infection over five years in a rural Ugandan population: cohort study. BMJ 1997; 315: 767-71.
3. Sewankambo NK, Wawer MJ, Gray RH, Serwadda D, Li C, Stallings RY, et al. Demographic impact of HIV infection in rural Rakai District, Uganda: results of a population-based cohort study. AIDS 1994; 8: 1707-14.
4. Nyirenda M, Hosegood V, Barnighausen T, Newell ML. Mortality levels and trends by HIV serostatus in rural South Africa. AIDS 2007; 21(Suppl 6): S73-9.
5. Marston M, Todd J, Glynn JR, Nelson KE, Rangsin R, Lutalo T, et al. Estimating 'net' HIV-related mortality and the importance of background mortality rates. AIDS 2007; 21(Suppl 6): S65-71.
6. Kasamba I, Baisley K, Mayanja BN, Maher D, Grosskurth H. The impact of antiretroviral treatment on mortality trends of HIV-positive adults in rural Uganda: a longitudinal populationbased study, 1999-2009. Trop Med Int Health 2012; 17: e66-73.
7. Marston M, Michael D, Wringe A, Isingo R, Clark BD, Jonas A, et al. The impact of antiretroviral therapy on adult mortality in rural Tanzania. Trop Med Int Health 2012; 17: e58-65.
8. Gargano JW, Laserson K, Muttai H, Odhiambo F, Orimba V, Adamu-Zeh M, et al. The adult population impact of HIV care and antiretroviral therapy in a resource poor setting, 2003-2008. AIDS 2012; 26(12): 1545-54.
9. Floyd S, Marston M, Baisley K, Wringe A, Herbst K, Chihana M, et al. The effect of antiretroviral therapy provision on allcause, AIDS and non-AIDS mortality at the population level - a comparative analysis of data from four settings in Southern and East Africa. Trop Med Int Health 2012; 17: e84-93.
10. Reniers G, Araya T, Davey G, Nagelkerke N, Berhane Y, Coutinho R, et al. Steep declines in population-level AIDS mortality following the introduction of antiretroviral therapy in Addis Ababa, Ethiopia. AIDS 2009; 23: 511-18.
11. The Antiretroviral Therapy in Lower Income Countries (ARTLINC) Collaboration, ART Cohort Collaboration (ART-CC) groups. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 2006; 367: 817-24.
12. Wringe A, Floyd S, Kazooba P, Mushati P, Baisley K, Urassa M, et al. Antiretroviral therapy uptake and coverage in four HIV community cohort studies in sub-Saharan Africa. Trop Med Int Health 2012; 17: e38-48.
13. Lawn SD, Harries AD, Wood R. Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settings. Curr Opin HIV AIDS 2010; 5: 18-26.
14. Masiira B, Baisley K, Mayanja BN, Kazooba P, Maher D, Kaleebu P. Mortality and its predictors among antiretroviral therapy naive HIV-infected individuals with CD4 cell count ]350 cells/mm (3) compared to the general population: data from a population-based prospective HIV cohort in Uganda. Glob Health Action 2014; 7: 21843.
15. Michael D, Kanjala C, Calvert C, Pretorius C, Wringe A, Todd J, et al. Does the Spectrum model accurately predict trends in adult mortality? Evaluation of model estimates using empirical data from a rural HIV community cohort study in North- Western Tanzania. Glob Health Action 2014; 7: 21783.
16. Nabukalu D, Klipstein-Grobusch K, Herbst K, Newell ML. Mortality in women of reproductive age in rural South Africa. Glob Health Action 2013; 6: 22834.
17. Tenu F, Isingo R, Zaba B, Urassa M, Todd J. Adjusting the HIV prevalence for non-respondents using mortality rates in an open cohort in northwest Tanzania. Tropical Medicine & International Health 2014. doi: 10.1111/tmi.12304.
18. Crampin AC, Dube A, Mboma S, Price A, Chihana M, Jahn A, et al. Profile: the Karonga Health and Demographic Surveillance System. Int J Epidemiol 2012; 41: 676-85.
19. Tanser F, Hosegood V, Barnighausen T, Herbst K, Nyirenda M, Muhwava W, et al. Cohort profile: Africa Centre Demographic Information System (ACDIS) and population-based HIV survey. Int J Epidemiol 2008; 37: 956-62.
20. Bärnighausen T, Tanser F, Malaza A, Herbst K, Newell ML. HIV status and participation in HIV surveillance in the era of antiretroviral treatment: a study of linked population-based and clinical data in rural South Africa. Trop Med Int Health 2012; 17: e103-10.
21. Urassa M, Boerma JT, Isingo R, Ngalula J, Ng'weshemi J, Mwaluko G, et al. The impact of HIV/AIDS on mortality and household mobility in rural Tanzania. AIDS 2001; 15: 2017-23.
22. Mbulaiteye S, Mahe C, Ruberantwari A, Whitworth J. Generalizability of population-based studies on AIDS: a comparison of newly and continuously surveyed villages in rural southwest Uganda. Int J Epidemiol 2002; 31: 961-7.
23. Crampin AC, Glynn JR, Fine PE.What has Karonga taught us? Tuberculosis studied over three decades. Int J Tuberc Lung Dis 2009; 13: 153-64.
24. Sewankambo NK, Gray RH, Ahmad S, Serwadda D, Wabwire- Mangen F, Nalugoda F, et al. Mortality associated with HIV infection in rural Rakai District, Uganda. AIDS 2000; 14: 2391-400.
25. Chihana M, Floyd S, Molesworth A, Crampin AC, Kayuni N, Price A, et al. Adult mortality and probable cause of death in rural northern Malawi in the era of HIV treatment. Trop Med Int Health 2012; 17: e74-83.
26. Rodger AJ, Lodwick R, Schechter M, Deeks S, Amin J, Gilson R, et al. Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population. AIDS 2013; 27: 973-9.
27. The Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord, Lewden C, Bouteloup V, De Wit S, Sabin C, Mocroft A, et al. All-cause mortality in treated HIV-infected adults with CD4 ]500/mm3 compared with the general population: evidence from a large European observational cohort collaboration. Int J Epidemiol 2012; 41: 433-45.
28. Brinkhof MWG, Boulle A, Weigel R, Messou E, Mathers C, Orrell C, et al. Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality. PLoS Med 2009; 6: e1000066.
29. The Antiretroviral Therapy Cohort Collaboration. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis 2010; 50: 1387-96.
30. The Antiretroviral Therapy Cohort Collaboration. Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries. Int J Epidemiol 2009; 38: 1624-33.
31. Hosegood V, Vanneste A-M, Timæus IM. Levels and causes of adult mortality in rural South Africa: the impact of AIDS. AIDS 2004; 18: 663-71.
32. Ortblad KF, Lozano R, Murray CJL. The burden of HIV: insights from the GBD 2010. AIDS 2013; 27: 2003-17.